BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20567140)

  • 1. The relationship between papillary infarction and microinvasion in ovarian atypical proliferative ("borderline") serous and seromucinous tumors.
    Kraus JA; Seidman JD
    Int J Gynecol Pathol; 2010 Jul; 29(4):303-9. PubMed ID: 20567140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
    Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
    Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.
    Sangoi AR; McKenney JK; Dadras SS; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):261-8. PubMed ID: 18223329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
    Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
    Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
    Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
    Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma.
    Choi CH; Kim TJ; Kim WY; Ahn GH; Lee JW; Kim BG; Lee JH; Bae DS
    Gynecol Oncol; 2007 Jun; 105(3):762-8. PubMed ID: 17383715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases.
    Maniar KP; Wang Y; Visvanathan K; Shih IeM; Kurman RJ
    Am J Surg Pathol; 2014 Jun; 38(6):743-55. PubMed ID: 24441661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic washing cytology in serous borderline tumors of the ovary using ThinPrep: are there cytologic clues to detecting tumor cells?
    Sadeghi S; Ylagan LR
    Diagn Cytopathol; 2004 May; 30(5):313-9. PubMed ID: 15108228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion?
    Kim KR; Lee HI; Lee SK; Ro JY; Robboy SJ
    Am J Surg Pathol; 2007 Apr; 31(4):546-54. PubMed ID: 17414101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic subtypes and laterality of primary epithelial ovarian tumors.
    Boger-Megiddo I; Weiss NS
    Gynecol Oncol; 2005 Apr; 97(1):80-3. PubMed ID: 15790441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.
    Choi YL; Kim SH; Shin YK; Hong YC; Lee SJ; Kang SY; Ahn G
    Gynecol Oncol; 2005 May; 97(2):379-86. PubMed ID: 15863133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian serous surface papillary borderline tumors form sea anemone-like masses.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Nishida M; Yoshikawa H; Saida T; Minami M
    J Magn Reson Imaging; 2011 Mar; 33(3):633-40. PubMed ID: 21287653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant role of MIB1 index in differentiating serous ovarian tumors-preliminary report.
    Frigerio L; Agnello A; Sassi I; Mangili F; Taccagni G; Mariani A; Ferrari A
    Anticancer Res; 1997; 17(2B):1287-92. PubMed ID: 9137487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the landscape of ovarian serous borderline tumors.
    Messini I; Doulgeraki T; Chrysanthakis D; Yiannou P; Gavresea T; Papadimitriou C; Panoskaltsis T; Voulgaris Z; Vlachos A; Pavlakis K
    Int J Gynecol Cancer; 2019 Mar; 29(3):572-578. PubMed ID: 30659030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.